United Therapeutics Corporation (UTHR) gains after earnings misses
United Therapeutics Corporation (UTHR) gains 0.3% even as earnings miss expectations, with investors weighing the latest results against the company’s outlook and pipeline progress.

United Therapeutics Corporation (UTHR) gains after earnings miss
United Therapeutics Corporation (UTHR) missed EPS estimates at $5.71 versus $6.01 but beat revenue estimates at $0.83B versus $0.78B, while shares gained 0.34% to $603.36 in regular-session trading.
Key Numbers
- EPS: $5.71 actual versus $6.01 estimated, a miss.


